Experimental Drug Offers Hope for Rare Bone Dise... (ia that isn't available in sufficient qu...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Experimental Drug Offers Hope for Rare Bone Disease: Study

Date:3/7/2012

ia that isn't available in sufficient quantity is called alkaline phosphatase. It's responsible for the mineralization of bones and teeth. Mineralization is the process that causes minerals like calcium and phosphorus to be deposited in developing bones and teeth, according to the National Library of Medicine. Without enough alkaline phosphatase, several other substances can build up and cause damage.

There are no approved medical treatments for hypophosphatasia, according to the study.

The current study involved 11 children. All were given an initial intravenous infusion of asfotase alfa, followed by shots of the medication three times a week.

Parents of one baby removed their child from the trial during the initial intravenous treatment. A second baby died from an unrelated infection after more than seven months of treatment.

The remaining nine children have received at least 18 months of treatment with asfotase alfa.

X-rays taken at the start of the study and at weeks 24 and 48 showed significant improvement in bone formation after treatment. In addition, the babies showed improvement in lung function, physical skills, and in the development of intelligence, according to the study.

The treatment was "very well tolerated," Whyte said. And, he added, there was no evidence that the children were developing resistance to the drug.

Treatment with asfotase alfa needs to be ongoing, and it's not yet clear if there are long-term side effects. Whyte and his colleagues are continuing to study the patients enrolled in this trial. He said that he believes children born with the severe or life-threatening form of the disease should be given this medication, even though it's still considered experimental. The reason, he said, is the severe form of this disease is "invariably lethal, usually soon after birth."

Dr. Spyros Mezitis, an endocrinologist at Lenox Hill Hospital in New York City, said the research is promising an
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Experimental Drug Offers Hope for Cystic Fibrosis Patients
2. Experimental Vaccine Shields Monkeys Against Ebola
3. Experimental targeted therapy shows early promise against medulloblastomas
4. Experimental nonsteroidal treatment of asthma shows promise
5. Experimental obesity drug avoids brain effects that troubled predecessors
6. Experimental treatments for cocaine addiction may prevent relapse
7. Experimental TB Test Called Fast and Accurate
8. Experimental Drug Shows Promise for Bone Marrow Disorder
9. Experimental Leukemia Drug Proves a Slam Dunk
10. Experimental Test May Spot Prostate Cancer Earlier, More Accurately
11. Experimental Drug Aids Kids With Nervous System Tumor

Post Your Comments:

Related Image:

Experimental Drug Offers Hope for Rare Bone Disease: Study

(Date:5/19/2013)... 2013 These molecular diagnostics market ... Spain, Japan, Italy, Germany and France:, ... laboratory practice, as well as key economic, regulatory, ... impact during the next five years. , ... technologies, test formats, detection methodologies, trends in testing ...

(Date:5/19/2013)... May 19, 2013 Americans live closer ... the newest American Veterinary Medical Association (AVMA) U.S. Pet ... dog owners consider their dog a member of the ... said as much five years earlier. , According to ... of the national income dedicated to pets has increased ...

(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...

(Date:5/19/2013)... Passages Malibu, the leading non-12 step, holistic, and ... the launch of a “Sobriety, Health, and Wellness” survey ... “We are always looking for new ways to engage ... regarding sobriety, what’s working for people, and what isn’t,” ... Passages Addiction Treatment Centers located in Malibu and ...

(Date:5/19/2013)... HealthEconomics.Com , the global leader ... unveil a new and exciting service: HE-Xpo: a media-rich, ... array of real-time communication tools to expand their digital ... , HE-Xpo is powered by OnStream Media’s ... feel of being at a physical trade show, all ...

Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3 Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2 Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3 Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2 Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3

[0] Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com [0] Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing [0] VegasHotelEscapes.com Announces Special Vegas Packages For Billboard Music Awards [0] Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey [0] HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access

... Programs During the Quarter, PALO ALTO, Calif., Nov. ... announced financial results for,the quarter ended September 30, 2007. ... of 2007 was $19.4,million, compared to net income of ... in the quarter ended September 30, 2006 included $31.6,million ...

... NEW YORK, Nov. 6 Weight Watchers,International, Inc. (NYSE: ... 29, 2007. Third Quarter 2007 Results For the ... to $337.5 million, up from $284.8 million in the third ... in the third quarter,of 2007 to $0.62 versus $0.52 in ...

... looks at hospital discharge rates in Raleigh and 6 ... ... County EMS has,participated in a seven-city study on the impact of new ... Heart,Association,s new 2005 CPR guidelines, according to the study authors in a,presentation ...

... rates in Cypress Creek and ... 6 other cities, ... in a seven-city study on the impact of new CPR techniques,the results ... CPR guidelines, according to the study authors in a,presentation at the AHA,s ...

... with Cardiac Resynchronization Therapy, researchers say , TUESDAY, Nov. ... a device that synchronizes pumping in the heart,s ventricles ... The results were presented Tuesday at a late-breaking clinical ... in Orlando, Fla., and were expected to be published ...

... Institute of Allergy and Infectious Diseases (NIAID), part of ... to strengthen and expand its nationwide group of institutions ... for infectious diseases. In addition to increasing the number ... Vaccine and Treatment Evaluation Units (VTEUs) to carry out ...

Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results Weight Watchers Announces Third Quarter 2007 Results Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device Cypress Creek in National Study, Shows Survival To Hospital Discharge After Cardiac Arrest Doubles with Improved CPR and Impedance Threshold Device Cardiac Device Won't Help Some Heart Failure Patients NIAID strengthens and expands Vaccine and Treatment Evaluation Units

(Date:5/17/2013)... CHAPEL HILL, N.C. , May 17, 2013 ... on how organizations communicate internally. Faced with a ... adjust their strategies and tactics for communicating with ... the effectiveness of all the strategies, tactics and ... In a new study, Best ...

(Date:5/17/2013)... 17, 2013 Sony Biotechnology Inc. ("Sony") today announced ... (SP6800). Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22. The ... commercial audio-visual technologies into new and novel functionalities for ...

(Date:5/17/2013)... TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...

Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2 Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2 TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2

[0] Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness [0] Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color [0] TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map

... PARK, Calif., Sept. 14 Praxis EMR has submitted its ... EMRs to apply for HITECH certification in the country. Under ... in federal incentives if they can demonstrate "meaningful use" of ... the U.S. Department of Health and Human Services to test ...

... Reportlinker.com announces that a new market research ... Autistic Disorder - Pipeline Assessment and Market ... Autistic Disorder - Pipeline ... SummaryGlobalData, the industry analysis specialist, has released ...

Cached Medicine Technology:Praxis EMR Among First to Apply for HITECH Certification 2 Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 2 Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 3

Praxis EMR Among First to Apply for HITECH Certification Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Xylocaine White Blood Cell Count Western Equine Encephalitis Antibody, IgM by IFA, Serum West Nile Virus RNA by RT-PCR